Koers BioNTech SE Xetra
Aandelen
US09075V1026
Biotechnologie & Medisch Onderzoek
Geschatte realtime
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
78,78 EUR | -22,08% |
|
+2,41% | +38,53% |
Omzet 2024 * | 2,75 mld. 2,94 mld. | Omzet 2025 * | 2,74 mld. 2,93 mld. | Marktkapitalisatie | 19,02 mld. 20,35 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -419 mln. -448 mln. | Nettowinst (verlies) 2025 * | -548 mln. -586 mln. | EV/omzet 2024 * | 2,31 x |
Nettoliquiditeiten 2024 * | 12,67 mld. 13,56 mld. | Nettoliquiditeiten 2025 * | 12,02 mld. 12,86 mld. | EV/omzet 2025 * | 2,56 x |
K/w-verhouding 2024 * |
-43,6
x | K/w-verhouding 2025 * |
-34,5
x | Werknemers | - |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 86,48% |
Recentste transcriptie over BioNTech SE
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ugur Sahin
CEO | Chief Executive Officer | 58 | 02-06-08 |
Özlem Türeci
FOU | Founder | 57 | 02-06-08 |
Jens Holstein
DFI | Director of Finance/CFO | 60 | 01-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Rudolf Staudigl
BRD | Director/Board Member | 70 | 01-01-22 |
Director/Board Member | 67 | 02-06-08 | |
Helmut Jeggle
CHM | Chairman | 53 | 02-06-08 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,45% | 122 mld. | |
+21,96% | 116 mld. | |
+23,87% | 27,03 mld. | |
-16,28% | 15,91 mld. | |
-16,52% | 16,43 mld. | |
-44,35% | 15,6 mld. | |
+63,91% | 14,94 mld. | |
+2,52% | 13,59 mld. | |
+124,94% | 11,24 mld. |
- Beurs
- Aandelen
- Koers BNTX
- Koers